G1 Therapeutics And Deimos Biosciences In License Deal For Lerociclib For Radioprotective Uses

(RTTNews) - G1 Therapeutics, Inc. (GTHX), a commercial-stage oncology company, and Deimos Biosciences, a portfolio company of Jupiter Bioventures,...

Related Keywords

China ,Japan ,Genor Biopharma ,Jupiter Bioventures ,Therapeutics Inc ,National Medical Products Administration ,Deimos Biosciences ,Deimos Bioscience ,Pepper Bio ,